JPRN-UMIN000001363已完成未知
Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events - - Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Subjects who were diagnosed with type 1 diabetes mellitus (2)Subjects with a BMI of <22 and a fasting IRI of <5 mU/mL (3)Subjects who required insulin therapy to control the blood glucose of diabetes mellitus, or who were on insulin therapy (4)Subjects with a history of hepatic function disorder due to the use of thiazolidinediones (e.g., troglitazone and pioglitazone) (5)Subjects currently on pioglitazone therapy (6)Subjects who had cardiac failure or a history thereof (7)Subjects with cardiovascular disorders (those who met the following conditions) 1)Subjects with onset of myocardial infarction within 6 months 2)Subjects who received hospital treatment for acute coronary syndrome within 3 months 3) Subjects who underwent coronary artery bypass surgery or percutaneous transluminal coronary angioplasty within 6 months (8)Subjects with the complication of severe arrhythmia (9)Subjects with cerebrovasculardisorders [those with onset of cerebrovascular disorder (excluding TIA)] (10)Subjects who needed management of their blood glucose by insulin injection, due to severe infection, before or after operation, or serious traumatic injury (11)Subjects with scheduled coronary artery bypass surgery, percutaneous transluminal coronary angioplasty, or surgery for leg ischemia
研究者
相似试验
已完成
不适用
Therapeutic Effect of Pioglitazone in Diabetic Patients with Renal TransplantatioCondition 1: Insulin-dependent diabetes mellitus. Condition 2: Non-insulin-dependent diabetes mellitus. Condition 3: Kidney transplant failure and rejection.Insulin-dependent diabetes mellitusNon-insulin-dependent diabetes mellitusKidney transplant failure and rejectionIRCT2014050117413N2Shahid Beheshti University of Medical Sciences58
进行中（未招募）
不适用
Pilot trial studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients with Type II Diabetes and Insulin Resistance undergoing elective PTCAEUCTR2006-002237-20-DETakeda Pharma GmbH
已完成
2 期
Study of efficacy and side effects of Pioglitazone in the treatment of psoriasisPsoriasis vulgarisPsoriasis.IRCT138903013862N2Research Council of Mashhad University of Medical Sciences26
已完成
不适用
A study to investigate the effect of pioglitazone on whole body and myocardial glucose uptake and myocardial blood flow/coronary vasodilator reserve in patients with familial combined hyperlipidaemiaISRCTN78563659Takeda Europe R and D Centre (UK)26
招募中
不适用
Comparison of efficacy and safety of pioglitazone versus metformin for moderate-to-severe chronic plaque psoriasis in patients with prediabetes or newly-diagnosed diabetes who have never taken anti-diabetic agents: a parallel, randomized, open-label, prospective studypsoriasisprediabetesdiabetes mellitusplaquepsoriasisprediabetesdiabetes mellitusTCTR20190724005Dermatological Society of Thailand (pending)40